Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
234.13
+12.17 (5.48%)
At close: Dec 5, 2025, 4:00 PM EST
235.00
+0.87 (0.37%)
After-hours: Dec 5, 2025, 7:58 PM EST
Krystal Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 198.91 | 89.16 | 10.93 | -139.98 | -69.57 | -32.17 | |
| Depreciation & Amortization | 2.14 | 3.21 | 4.81 | 3.39 | 2.77 | 1.85 | |
| Loss (Gain) From Sale of Assets | - | - | -100 | - | - | 0.03 | |
| Loss (Gain) From Sale of Investments | -7.22 | -7.78 | -7.28 | 0.1 | - | - | |
| Stock-Based Compensation | 54.11 | 49.13 | 39.93 | 33.23 | 15.32 | 3.27 | |
| Other Operating Activities | -20.16 | 4.15 | 1.32 | 0.03 | 1.04 | 0.01 | |
| Change in Accounts Receivable | -32.07 | -62.71 | -42.04 | - | - | - | |
| Change in Inventory | -11.75 | -11.91 | -4.48 | - | - | - | |
| Change in Accounts Payable | 0.42 | 1.01 | -0.1 | -1.25 | 0.71 | 0.78 | |
| Change in Other Net Operating Assets | -8.18 | 59.15 | 8.09 | 3.91 | 1.79 | 0.13 | |
| Operating Cash Flow | 176.2 | 123.42 | -88.8 | -100.57 | -47.94 | -26.08 | |
| Capital Expenditures | -10.61 | -4.24 | -11.8 | -52.98 | -68.34 | -14.84 | |
| Sale of Property, Plant & Equipment | 0.44 | - | 100 | - | - | - | |
| Investment in Securities | -143.18 | -159.2 | -5.56 | -61.1 | -158.43 | 3.66 | |
| Investing Cash Flow | -153.36 | -163.44 | 82.64 | -114.08 | -226.77 | -11.18 | |
| Issuance of Common Stock | 9.4 | 32.4 | 203.5 | 36 | 355.65 | 118.02 | |
| Repurchase of Common Stock | -13.93 | -5.39 | -0.75 | -0.65 | - | - | |
| Other Financing Activities | - | - | - | - | -7.96 | - | |
| Financing Cash Flow | -4.53 | 27.01 | 202.75 | 35.35 | 347.69 | 118.02 | |
| Foreign Exchange Rate Adjustments | 0.33 | -0.46 | -0.16 | -0.04 | - | - | |
| Net Cash Flow | 18.64 | -13.46 | 196.43 | -179.35 | 72.98 | 80.76 | |
| Free Cash Flow | 165.59 | 119.18 | -100.6 | -153.55 | -116.27 | -40.93 | |
| Free Cash Flow Margin | 44.37% | 41.02% | -198.43% | - | - | - | |
| Free Cash Flow Per Share | 5.54 | 4.01 | -3.63 | -6.02 | -5.24 | -2.18 | |
| Cash Income Tax Paid | 14.39 | 5.67 | - | - | - | - | |
| Levered Free Cash Flow | 76.2 | 92.96 | -74.61 | -90.02 | -85.35 | -19.98 | |
| Unlevered Free Cash Flow | 76.2 | 92.96 | -74.61 | -90.02 | -84.41 | -19.98 | |
| Change in Working Capital | -51.58 | -14.46 | -38.52 | 2.66 | 2.51 | 0.92 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.